AU7494594A - Benzoxazinones and benzothiazinones endowed with therapeutic activity - Google Patents

Benzoxazinones and benzothiazinones endowed with therapeutic activity

Info

Publication number
AU7494594A
AU7494594A AU74945/94A AU7494594A AU7494594A AU 7494594 A AU7494594 A AU 7494594A AU 74945/94 A AU74945/94 A AU 74945/94A AU 7494594 A AU7494594 A AU 7494594A AU 7494594 A AU7494594 A AU 7494594A
Authority
AU
Australia
Prior art keywords
benzothiazinones
benzoxazinones
endowed
therapeutic activity
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74945/94A
Other languages
English (en)
Inventor
Francesca Benedini
Giorgio Bertolini
Gianni Gromo
Silvio Levi
Jacques Mizrhai
Alberto Sala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of AU7494594A publication Critical patent/AU7494594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/041,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/081,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU74945/94A 1993-07-28 1994-07-18 Benzoxazinones and benzothiazinones endowed with therapeutic activity Abandoned AU7494594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT93MI001678A IT1264812B1 (it) 1993-07-28 1993-07-28 Derivati benzossazinonici e benzotiazinonici terapeuticamente attivi
ITMI93A1678 1993-07-28
PCT/EP1994/002354 WO1995004048A1 (en) 1993-07-28 1994-07-18 Benzoxazinones and benzothiazinones endowed with therapeutic activity

Publications (1)

Publication Number Publication Date
AU7494594A true AU7494594A (en) 1995-02-28

Family

ID=11366700

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74945/94A Abandoned AU7494594A (en) 1993-07-28 1994-07-18 Benzoxazinones and benzothiazinones endowed with therapeutic activity

Country Status (13)

Country Link
EP (1) EP0711286A1 (fi)
JP (1) JPH09500878A (fi)
CN (1) CN1128025A (fi)
AU (1) AU7494594A (fi)
CA (1) CA2168099A1 (fi)
FI (1) FI960342A0 (fi)
HU (1) HUT74587A (fi)
IL (1) IL110473A0 (fi)
IT (1) IT1264812B1 (fi)
NO (1) NO960308L (fi)
TW (1) TW277061B (fi)
WO (1) WO1995004048A1 (fi)
ZA (1) ZA945555B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102367239B (zh) * 2011-07-20 2015-10-28 沈阳药科大学 2-芳基-2,3-二氢-4h-1,3-苯并噻嗪-4-酮衍生物及其用途
JP6132915B2 (ja) 2012-08-27 2017-05-24 ユニバーシティ オブ テネシー リサーチ ファウンデーション Lpa2受容体特異的安息香酸誘導体
ITMI20122221A1 (it) * 2012-12-21 2014-06-22 C4T S C A R L Nuovi composti del 2,3-diidro-4h-1,3-benzossazin-4-one, metodo per prepararli e forma farmaceutica che li comprende
EP3083608B1 (en) * 2013-12-19 2018-07-18 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2443M (fr) * 1962-10-30 1964-04-06 Selvi & C Lab Bioterapico Thio-dérivés de benzo-oxazine ayant des propriétés antiphlogistiques, antipyrétiques et analgésiques.
US3459748A (en) * 1967-04-28 1969-08-05 Squibb & Sons Inc Hydroxyalkylene-substituted benzoxazines and benzothiazines
IT1136575B (it) * 1981-04-15 1986-09-03 Coli Farma Lab Esteri del 2-(2-ossietil)-2,3-diidro-h4-1,3-benzossazin-4-one ad attivita' analgesica e procedimento per la loro preparazione
IT1244472B (it) * 1990-12-14 1994-07-15 Italfarmaco Spa Benzossazinoni e benzotiazinoni ad attivita' cardiovascolare
FR2680172B1 (fr) * 1991-08-05 1993-11-19 Fabre Medicament Pierre Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
IT1254884B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Benzossazinoni e benzotiazinoni ad attivita' cardiovascolare

Also Published As

Publication number Publication date
EP0711286A1 (en) 1996-05-15
CN1128025A (zh) 1996-07-31
HUT74587A (en) 1997-01-28
WO1995004048A1 (en) 1995-02-09
FI960342A (fi) 1996-01-25
FI960342A0 (fi) 1996-01-25
ITMI931678A1 (it) 1995-01-28
NO960308L (no) 1996-03-13
JPH09500878A (ja) 1997-01-28
ZA945555B (en) 1995-03-03
CA2168099A1 (en) 1995-02-09
IL110473A0 (en) 1994-10-21
TW277061B (fi) 1996-06-01
ITMI931678A0 (it) 1993-07-28
IT1264812B1 (it) 1996-10-10
HU9600165D0 (en) 1996-03-28
NO960308D0 (no) 1996-01-25

Similar Documents

Publication Publication Date Title
AU7731694A (en) Pacing and defibrillating lead with sensing capability
AU6665894A (en) Integrated battery contact and retentive protrusion
AU6352298A (en) Catheters and needle assemblies
AU7846594A (en) Improvements in safety needle and syringe
AU1970095A (en) Ring electrode construction and implantable leads using the same
AU6945094A (en) Padding body with individual modular elements
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU4383897A (en) Benzamidine derivatives and their use as medicaments with an LTB4-antagonistic activity
AU6709794A (en) Erythropoietin muteins with enhanced activity
AU6120994A (en) Anticonvulsive agents and uses thereof
AU7390994A (en) Molecular modelling and drug design
AU6772694A (en) Insecticidal pteridines and 8-deazapteridines
EP0551865A3 (en) Polycarbonate and use thereof
AU4415789A (en) Improved display and support assemblies
ZA941111B (en) Vpr function and activity
AU1636492A (en) Peptides having thrombospondin-like activity and their therapeutic use
AU6447894A (en) Golf glubs and methods
AU7392294A (en) Pharmaceutical with immunomodulating activity
AU5809594A (en) An enzyme with polygalacturonase activity
AU7494594A (en) Benzoxazinones and benzothiazinones endowed with therapeutic activity
AU1311595A (en) Novel quinoxalines and drugs prepared therefrom
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU7200591A (en) Aryl-propyl-amines endowed with antifungal activity
AU5646394A (en) Hinge arrangements, their construction and use
ZA959666B (en) Fluorenyl-hydroxamic derivatives endowed with immuno-suppressive and entinflammatory activity